← Leaderboards
Martin Latterich
Salk Institute For Biological Studies
$2,483,168
Attributed
$2,483,168
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $468.8K · FY2015–19$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,483,168 · 2
By mechanism
P01$2,256,933 · 1
R01$226,235 · 1
Top collaborators
No co-investigators on record.
Most similar at Salk Institute For Biological Studies
Same institution · by research overlap
- Martin W Hetzer$10,805,029
- Prafulla Aryal$76,719
Others in their field
Top investigators on “Injectable”
- Wafaa M. El-Sadr · Columbia University Health Sciences$288,484,824
- Myron S Cohen · Family Health International$248,617,295
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Susan H Eshleman · Johns Hopkins University$92,035,670
- Dan H. Barouch · Fred Hutchinson Cancer Center$88,047,584
- Georgia D Tomaras · Fred Hutchinson Cancer Center$80,305,907
Research focus
InjectableKineticsImmunoglobulin FragmentsGlycolsImmunoconjugatesAnimal ModelHybridomasAffectFibrosisEnsureImaging AgentBaseCharacteristicsChimeric ProteinsAntibodiesCopolymerCrosslinkDoseDrug Delivery SystemsAqueousBuffersEncapsulatedCaveolaeLabel
Grant awards (7)
Antibody Targeted Therapeutics$446,705
P01 · FY2019 · HL · contact PI
Antibody Targeted Therapeutics$446,881
P01 · FY2018 · HL · contact PI
Antibody Targeted Therapeutics$447,159
P01 · FY2017 · HL · contact PI
Antibody Targeted Therapeutics$447,369
P01 · FY2016 · HL · contact PI
Antibody Targeted Therapeutics$468,819
P01 · FY2015 · HL · contact PI
NUCLEAR CELL CYCLE AND MITOTIC MEMBRANE FUNCTION$113,875
R01 · FY2000 · GM
NUCLEAR CELL CYCLE AND MITOTIC MEMBRANE FUNCTION$112,360
R01 · FY2000 · GM